RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
VG Life Sciences - Stock

VG Life Sciences P/S 2024

VG Life Sciences P/S

0

Ticker

VGLS

ISIN

US91822T1016

WKN

A1J8VF

As of Jul 1, 2024, VG Life Sciences's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.

The VG Life Sciences P/S history

VG Life Sciences Aktienanalyse

What does VG Life Sciences do?

VG Life Sciences Inc is a California-based company that specializes in the research, development, and commercialization of new medical technologies and products. The company collaborates closely with researchers, academics, and professionals worldwide to develop and market innovative solutions for the healthcare industry. Its core business is the research and development of drugs based on plant substances and natural products. The company has developed a unique technology platform that allows for the selection of specific target molecules in the human body from thousands of natural compounds. These compounds are further studied and optimized to develop active ingredients for the treatment of various diseases. VG Life Sciences also has its own line of dietary supplements and skincare products based on natural ingredients. These products are available under the brand Vivid GLOW and are sold on online platforms and selected retail stores. The company also focuses on dietary supplements and uses its extensive medical expertise to develop high-quality products based on the latest research. These products are designed to promote overall health and enable a longer and more productive life. Another business area of VG Life Sciences is its laboratory services business. The company offers a wide range of services, from raw material analysis to drug formulation and clinical drug testing. It has significantly expanded its capabilities and now has a modern analysis and research laboratory equipped with the latest technological instruments and devices. The company also provides training and consulting services to support customers in the development and marketing of new medical products. VG Life Sciences is committed to ensuring high quality and scientific excellence in all business areas. To achieve this, the company has assembled a team of experienced researchers and scientists and collaborates with various academic and industry partners. It places great emphasis on compliance with standards and regulations and works closely with relevant authorities to ensure that its products and services meet the highest standards. Overall, VG Life Sciences Inc is an innovative and emerging company focused on the development and commercialization of new medical technologies and products. The company has a unique technology platform, a wide range of products and services, and a dedicated team of professionals. It strives to ensure high quality and scientific excellence in all business areas and to become a key player in the healthcare industry. VG Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding VG Life Sciences's P/S Ratio

VG Life Sciences's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing VG Life Sciences's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating VG Life Sciences's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in VG Life Sciences’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about VG Life Sciences Stock

What is the price-to-earnings ratio of VG Life Sciences?

The price-earnings ratio of VG Life Sciences is currently 0.

How has the price-earnings ratio of VG Life Sciences changed compared to last year?

The price-to-earnings ratio of VG Life Sciences has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of VG Life Sciences high compared to other companies?

Yes, the price-to-earnings ratio of VG Life Sciences is high compared to other companies.

How does an increase in the price-earnings ratio of VG Life Sciences affect the company?

An increase in the price-earnings ratio of VG Life Sciences would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of VG Life Sciences affect the company?

A decrease in the price-earnings ratio of VG Life Sciences would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of VG Life Sciences?

Some factors that influence the price-earnings ratio of VG Life Sciences are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does VG Life Sciences pay?

Over the past 12 months, VG Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, VG Life Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of VG Life Sciences?

The current dividend yield of VG Life Sciences is .

When does VG Life Sciences pay dividends?

VG Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of VG Life Sciences?

VG Life Sciences paid dividends every year for the past 0 years.

What is the dividend of VG Life Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is VG Life Sciences located?

VG Life Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von VG Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of VG Life Sciences from 7/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did VG Life Sciences pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of VG Life Sciences in the year 2023?

In the year 2023, VG Life Sciences distributed 0 USD as dividends.

In which currency does VG Life Sciences pay out the dividend?

The dividends of VG Life Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von VG Life Sciences

Our stock analysis for VG Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of VG Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.